MA
NUVB.WS

MYDA Advisors’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

MYDA Advisors’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-38,000
Closed -$11K – 192
2022
Q2 		$11K Hold
38,000
– – ﹤0.01% 191
2022
Q1 		$31K Hold
38,000
– – 0.01% 187
2021
Q4 		$72K Hold
38,000
– – 0.02% 223
2021
Q3 		$101K Hold
38,000
– – 0.03% 233
2021
Q2 		$99K Sell
38,000
-2,000
-5% -$6.52K 0.02% 256
2021
Q1 		$107K Buy
+40,000
New +$116K 0.03% 270

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MYDA Advisors's NUVB.WS Position: Q3 2022 in Review

MYDA Advisors sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q3 2022, closing a stake of 38,000 shares — an estimated $11K sold.

MYDA Advisors first reported a position in NUVB.WS in Q1 2021 and held it in 6 quarters. The position peaked at $107K in Q1 2021. 20 funds tracked by Wall St. Rank hold NUVB.WS as of Q3 2022.

  • MYDA Advisors reported no remaining Nuvation Bio Inc Warrants position as of Q3 2022 after selling out during the quarter.
  • MYDA Advisors sold 38,000 Nuvation Bio Inc Warrants shares in Q3 2022, an estimated $11K.
  • MYDA Advisors first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 6 quarters.
  • MYDA Advisors's Nuvation Bio Inc Warrants position peaked at $107K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q3 2022.

Based on MYDA Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.